title: Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study.
abstract: BACKGROUND
  Conflicting evidence exists regarding the association between saturated fatty acids (SFAs) and type 2 diabetes. In this longitudinal case-cohort study, we aimed to investigate the prospective associations between objectively measured individual plasma phospholipid SFAs and incident type 2 diabetes in EPIC-InterAct participants.
  
  
  METHODS
  The EPIC-InterAct case-cohort study includes 12,403 people with incident type 2 diabetes and a representative subcohort of 16,154 individuals who were selected from a cohort of 340.234 European participants with 3·99 million person-years of follow-up (the EPIC study). Incident type 2 diabetes was ascertained until Dec 31, 2007, by a review of several sources of evidence. Gas chromatography was used to measure the distribution of fatty acids in plasma phospholipids (mol%); samples from people with type 2 diabetes and subcohort participants were processed in a random order by centre, and laboratory staff were masked to participant characteristics. We estimated country-specific hazard ratios (HRs) for associations per SD of each SFA with incident type 2 diabetes using Prentice-weighted Cox regression, which is weighted for case-cohort sampling, and pooled our findings using random-effects meta-analysis.
  
  
  RESULTS
  SFAs accounted for 46% of total plasma phospholipid fatty acids. In adjusted analyses, different individual SFAs were associated with incident type 2 diabetes in opposing directions. Even-chain SFAs that were measured (14:0 [myristic acid], 16:0 [palmitic acid], and 18:0 [stearic acid]) were positively associated with incident type 2 diabetes (HR [95% CI] per SD difference: myristic acid 1·15 [95% CI 1·09-1·22], palmitic acid 1·26 [1·15-1·37], and stearic acid 1·06 [1·00-1·13]). By contrast, measured odd-chain SFAs (15:0 [pentadecanoic acid] and 17:0 [heptadecanoic acid]) were inversely associated with incident type 2 diabetes (HR [95% CI] per 1 SD difference: 0·79 [0·73-0·85] for pentadecanoic acid and 0·67 [0·63-0·71] for heptadecanoic acid), as were measured longer-chain SFAs (20:0 [arachidic acid], 22:0 [behenic acid], 23:0 [tricosanoic acid], and 24:0 [lignoceric acid]), with HRs ranging from 0·72 to 0·81 (95% CIs ranging between 0·61 and 0·92). Our findings were robust to a range of sensitivity analyses.
  
  
  CONCLUSIONS
  Different individual plasma phospholipid SFAs were associated with incident type 2 diabetes in opposite directions, which suggests that SFAs are not homogeneous in their effects. Our findings emphasise the importance of the recognition of subtypes of these fatty acids. An improved understanding of differences in sources of individual SFAs from dietary intake versus endogenous metabolism is needed.
  
  
  BACKGROUND
  EU FP6 programme, Medical Research Council Epidemiology Unit, Medical Research Council Human Nutrition Research, and Cambridge Lipidomics Biomarker Research Initiative.
authors.affiliation: MRC Epidemiology Unit, University of Cambridge, Cambridge, UK. Electronic address: nita.forouhi@mrc-epid.cam.ac.uk.
authors.forename: Nita G
authors.initials: NG
authors.lastname: Forouhi
authors.affiliation: MRC Human Nutrition Research, Cambridge, UK.
authors.forename: Albert
authors.initials: A
authors.lastname: Koulman
authors.affiliation: MRC Epidemiology Unit, University of Cambridge, Cambridge, UK.
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Sharp
authors.affiliation: MRC Epidemiology Unit, University of Cambridge, Cambridge, UK.
authors.forename: Fumiaki
authors.initials: F
authors.lastname: Imamura
authors.affiliation: German Institute of Human Nutrition Potsdam-Rehbruecke, Potsdam, Germany.
authors.forename: Janine
authors.initials: J
authors.lastname: Kröger
authors.affiliation: German Institute of Human Nutrition Potsdam-Rehbruecke, Potsdam, Germany.
authors.forename: Matthias B
authors.initials: MB
authors.lastname: Schulze
authors.affiliation: Nuffield Department of Medicine, University of Oxford, Oxford, UK.
authors.forename: Francesca L
authors.initials: FL
authors.lastname: Crowe
authors.affiliation: Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Murcia, Spain.
authors.forename: José María
authors.initials: JM
authors.lastname: Huerta
authors.affiliation: CIBER Epidemiología y Salud Pública (CIBERESP), Murcia, Spain; Navarre Public Health Institute (ISPN), Pamplona, Spain.
authors.forename: Marcela
authors.initials: M
authors.lastname: Guevara
authors.affiliation: University Medical Center Utrecht, Utrecht, Netherlands.
authors.forename: Joline W J
authors.initials: JW
authors.lastname: Beulens
authors.affiliation: Wageningen University, Wageningen, Netherlands.
authors.forename: Geertruida J
authors.initials: GJ
authors.lastname: van Woudenbergh
authors.affiliation: MRC Human Nutrition Research, Cambridge, UK.
authors.forename: Laura
authors.initials: L
authors.lastname: Wang
authors.affiliation: MRC Human Nutrition Research, Cambridge, UK.
authors.forename: Keith
authors.initials: K
authors.lastname: Summerhill
authors.affiliation: MRC Human Nutrition Research, Cambridge, UK.
authors.forename: Julian L
authors.initials: JL
authors.lastname: Griffin
authors.affiliation: Wageningen University, Wageningen, Netherlands.
authors.forename: Edith J M
authors.initials: EJ
authors.lastname: Feskens
authors.affiliation: CIBER Epidemiología y Salud Pública (CIBERESP), Murcia, Spain; Public Health Division of Gipuzkoa, San Sebastian, Spain; Instituto BIO-Donostia, Basque Government, San Sebastian, Spain.
authors.forename: Pilar
authors.initials: P
authors.lastname: Amiano
authors.affiliation: German Institute of Human Nutrition Potsdam-Rehbruecke, Potsdam, Germany.
authors.forename: Heiner
authors.initials: H
authors.lastname: Boeing
authors.affiliation: Inserm, CESP, U1018, Villejuif, France; Univ Paris-Sud, UMRS 1018, Villejuif, France; Gustave Roussy Institute, F-94800 Villejuif, France.
authors.forename: Françoise
authors.initials: F
authors.lastname: Clavel-Chapelon
authors.affiliation: Inserm, CESP, U1018, Villejuif, France; Univ Paris-Sud, UMRS 1018, Villejuif, France; Gustave Roussy Institute, F-94800 Villejuif, France.
authors.forename: Laureen
authors.initials: L
authors.lastname: Dartois
authors.affiliation: Inserm, CESP, U1018, Villejuif, France; Univ Paris-Sud, UMRS 1018, Villejuif, France; Gustave Roussy Institute, F-94800 Villejuif, France.
authors.forename: Guy
authors.initials: G
authors.lastname: Fagherazzi
authors.affiliation: Lund University, Malmö, Sweden; Umeå University, Umeå, Sweden.
authors.forename: Paul W
authors.initials: PW
authors.lastname: Franks
authors.affiliation: Catalan Institute of Oncology (ICO), Barcelona, Spain.
authors.forename: Carlos
authors.initials: C
authors.lastname: Gonzalez
authors.affiliation: Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark.
authors.forename: Marianne Uhre
authors.initials: MU
authors.lastname: Jakobsen
authors.affiliation: German Cancer Research Centre (DKFZ), Heidelberg, Germany.
authors.forename: Rudolf
authors.initials: R
authors.lastname: Kaaks
authors.affiliation: Nuffield Department of Medicine, University of Oxford, Oxford, UK.
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Key
authors.affiliation: Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
authors.forename: Kay-Tee
authors.initials: KT
authors.lastname: Khaw
authors.affiliation: German Cancer Research Centre (DKFZ), Heidelberg, Germany.
authors.forename: Tilman
authors.initials: T
authors.lastname: Kühn
authors.affiliation: Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
authors.forename: Amalia
authors.initials: A
authors.lastname: Mattiello
authors.affiliation: Lund University, Malmö, Sweden.
authors.forename: Peter M
authors.initials: PM
authors.lastname: Nilsson
authors.affiliation: Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark; Aalborg University Hospital, Aalborg, Denmark.
authors.forename: Kim
authors.initials: K
authors.lastname: Overvad
authors.affiliation: Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
authors.forename: Valeria
authors.initials: V
authors.lastname: Pala
authors.affiliation: Cancer Research and Prevention Institute (ISPO), Florence, Italy.
authors.forename: Domenico
authors.initials: D
authors.lastname: Palli
authors.affiliation: Public Health Directorate, Asturias, Spain.
authors.forename: J Ramón
authors.initials: JR
authors.lastname: Quirós
authors.affiliation: Umeå University, Umeå, Sweden.
authors.forename: Olov
authors.initials: O
authors.lastname: Rolandsson
authors.affiliation: Danish Cancer Society, Copenhagen, Denmark.
authors.forename: Nina
authors.initials: N
authors.lastname: Roswall
authors.affiliation: Unit of Cancer Epidemiology, Citta' della Salute e della Scienza Hospital-University of Turin and Centre for Cancer Prevention (CPO), Turin, Italy; Human Genetics Foundation (HuGeF), Turin, Italy.
authors.forename: Carlotta
authors.initials: C
authors.lastname: Sacerdote
authors.affiliation: CIBER Epidemiología y Salud Pública (CIBERESP), Murcia, Spain; Andalusian School of Public Health, Granada, Spain; Instituto de Investigación Biosanitaria de Granada (Granada.ibs), Granada, Spain.
authors.forename: María-José
authors.initials: MJ
authors.lastname: Sánchez
authors.affiliation: International Agency for Research on Cancer, Lyon, France.
authors.forename: Nadia
authors.initials: N
authors.lastname: Slimani
authors.affiliation: National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
authors.forename: Annemieke M W
authors.initials: AM
authors.lastname: Spijkerman
authors.affiliation: Danish Cancer Society Research Center, Copenhagen, Denmark.
authors.forename: Anne
authors.initials: A
authors.lastname: Tjonneland
authors.affiliation: Department of Epidemiology, Murcia Regional Health Council, Murcia, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Murcia, Spain; Department of Health and Social Sciences, Universidad de Murcia, Spain.
authors.forename: Maria-José
authors.initials: MJ
authors.lastname: Tormo
authors.affiliation: Associazione Italiana Registri Tumori, Dipartimento di Prevenzione Medica, Azienda Sanitaria Provinciale, Ragusa, Italy; Aire Onlus, Ragusa, Italy.
authors.forename: Rosario
authors.initials: R
authors.lastname: Tumino
authors.affiliation: National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands.
authors.forename: Daphne L
authors.initials: DL
authors.lastname: van der A
authors.affiliation: University Medical Center Utrecht, Utrecht, Netherlands.
authors.forename: Yvonne T
authors.initials: YT
authors.lastname: van der Schouw
authors.affiliation: MRC Epidemiology Unit, University of Cambridge, Cambridge, UK.
authors.forename: Claudia
authors.initials: C
authors.lastname: Langenberg
authors.affiliation: School of Public Health, Imperial College London, London, UK.
authors.forename: Elio
authors.initials: E
authors.lastname: Riboli
authors.affiliation: MRC Epidemiology Unit, University of Cambridge, Cambridge, UK.
authors.forename: Nicholas J
authors.initials: NJ
authors.lastname: Wareham
mesh_terms: D016022:Case-Control Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000453:epidemiology*; D005227:Fatty Acids / Q000097:blood*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010743:Phospholipids / Q000097:blood*; D011446:Prospective Studies
chemical_list: D005227:Fatty Acids; D010743:Phospholipids
references.citation: Prog Lipid Res. 2013 Jan;52(1):15-42
references.pmid: 23000367
references.citation: Am J Clin Nutr. 1999 Jan;69(1):22-9
references.pmid: 9925119
references.citation: Am J Clin Nutr. 1999 Nov;70(5):928-36
references.pmid: 10539756
references.citation: Am J Clin Nutr. 2007 Jul;86(1):189-97
references.pmid: 17616780
references.citation: Am J Clin Nutr. 2011 Jan;93(1):127-42
references.pmid: 20980488
references.citation: Nutr Metab Cardiovasc Dis. 2008 Sep;18(7):503-10
references.pmid: 18042359
references.citation: Annu Rev Nutr. 2001;21:193-230
references.pmid: 11375435
references.citation: Diabetologia. 2014 May;57(5):909-17
references.pmid: 24510203
references.citation: Am J Clin Nutr. 1998 Aug;68(2):291-5
references.pmid: 9701185
references.citation: PLoS One. 2013;8(3):e59470
references.pmid: 23555678
references.citation: Diabetes Metab. 2008 Dec;34(6 Pt 2):643-8
references.pmid: 19195625
references.citation: Am J Clin Nutr. 2013 Apr;97(4):854-61
references.pmid: 23407305
references.citation: Diabet Med. 2002 Jun;19(6):456-64
references.pmid: 12060056
references.citation: Am J Clin Nutr. 2012 Aug;96(2):382-90
references.pmid: 22760573
references.citation: Lipids. 2010 Oct;45(10):893-905
references.pmid: 20354806
references.citation: Genome Med. 2013 Apr 25;5(4):39
references.pmid: 23618465
references.citation: Diabetes. 2001 Jan;50(1):69-76
references.pmid: 11147797
references.citation: Prog Lipid Res. 2008 Sep;47(5):348-80
references.pmid: 18435934
references.citation: Annu Rev Nutr. 1996;16:523-57
references.pmid: 8839937
references.citation: Arch Intern Med. 2008 Jul 28;168(14):1500-11
references.pmid: 18663162
references.citation: Eur J Clin Nutr. 2007 Sep;61(9):1037-56
references.pmid: 17375121
references.citation: Ann Intern Med. 2014 Mar 18;160(6):398-406
references.pmid: 24723079
references.citation: Am J Clin Nutr. 2010 Nov;92(5):1214-22
references.pmid: 20861175
references.citation: Am J Physiol Endocrinol Metab. 2009 Jan;296(1):E64-71
references.pmid: 18940935
references.citation: Am J Clin Nutr. 2006 Feb;83(2):227-36
references.pmid: 16469979
references.citation: Diabetologia. 2011 Sep;54(9):2272-82
references.pmid: 21717116
references.citation: J Clin Invest. 1996 May 1;97(9):2081-91
references.pmid: 8621798
references.citation: Am J Clin Nutr. 1998 Apr;67(4):631-9
references.pmid: 9537610
references.citation: Am J Clin Nutr. 2003 Jul;78(1):91-8
references.pmid: 12816776
references.citation: Circulation. 2004 Jun 29;109(25):3244-55
references.pmid: 15198946